Cargando…
Assessment of [(125)I]WYE-230949 as a Novel Histamine H(3) Receptor Radiopharmaceutical
Histamine H(3) receptor therapeutics have been proposed for several diseases such as schizophrenia, attention deficit hyperactivity disorder, Alzheimer's disease and obesity. We set out to evaluate the novel compound, [(125)I]WYE-230949, as a potential radionuclide imaging agent for the histami...
Autores principales: | Lewis, David Y., Champion, Sue, Wyper, David, Dewar, Deborah, Pimlott, Sally |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277420/ https://www.ncbi.nlm.nih.gov/pubmed/25542008 http://dx.doi.org/10.1371/journal.pone.0115876 |
Ejemplares similares
-
Santal monohydrate, an isoflavone isolated from Wyethia mollis
por: Knight, Kyle S., et al.
Publicado: (2014) -
Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice
por: Weber, Helga, et al.
Publicado: (2015) -
WYE-354 restores Adriamycin sensitivity in multidrug-resistant acute myeloid leukemia cell lines
por: Ibrahim, Sara M., et al.
Publicado: (2019) -
Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells
por: Wang, Jingqiu, et al.
Publicado: (2020) -
Histamine and H(1)-histamine receptors faster venous circulation
por: Galajda, Zoltan, et al.
Publicado: (2011)